Top Analyst Upgrades and Downgrades: Albermarle, BB&T, Cheniere, Chesapeake Energy, Kinder Morgan, Red Hat, Roku and More
China Unicom Ltd. (NYSE: CHU) was raised to Overweight from Underweight at Morgan Stanley.
Cintas Corp. (NASDAQ: CTAS) was started on the prized Conviction Buy List with a $210 price target (versus a $170.98 close) at Goldman Sachs.
Eldorado Gold Corp. (NYSE: EGO) was maintained as Neutral but the price target was cut to $1.25 from $1.60 (versus a $0.87 close) at Credit Suisse, with the firm noting lower production on Eldorado.
Finish Line Inc. (NASDAQ: FINL) was raised to Neutral from Sell and the price target was raised to $14 from $10 at Citigroup now that it is being acquired. Finish Line closed up 31% at $13.83 on Monday’s post-buyout offer reaction. It has a 52-week trading range of $6.90 to $16.38.
H&R Block Inc. (NYSE: HRB) was started as Neutral and assigned a $28 price target (versus a $25.79 close) at Goldman Sachs. The 52-week range is $22.40 to $31.80, and the consensus price target is $28.67.
Iron Mountain Inc. (NYSE: IRM) was started as Buy and assigned a $41 price target (versus a $31.27 close) at Goldman Sachs. It has a 52-week range of $30.78 to $41.53 and as a consensus price target of $37.50.
Kinder Morgan Inc. (NYSE: KMI) was raised to Buy from Neutral with a $21 price target (versus a $15.13 close) at Citigroup. The 52-week range is $14.82 to $21.92. The consensus analyst target is $22.00.
MEDNAX Inc. (NYSE: MD) was started as Neutral and assigned a $57 price target (versus a $55.06 close) at Credit Suisse. $57
Prologis Inc. (NYSE: PLD) was raised to Overweight from Neutral with a $68 price target (versus a $61.23 close) at JPMorgan. It has a 52-week range of $49.44 to $67.53 and a consensus price target of $69.11.
Rambus Inc. (NASDAQ: RMBS) was started as Buy and assigned a $17 price target (versus a $13.49 close) at Deutsche Bank. It has a 52-week range of $11.30 to $15.50 and a consensus price target of $16.95.
Red Hat Inc. (NYSE: RHT) was up 3.5% at $153.09 ahead of earnings on Monday and was indicated up 6% at $162.50 on Tuesday. BMP Capital Markets maintained its Market Perform rating but raised its target price to $180 from $172. Other target price hikes have been seen as follows: Credit Suisse to $150 from $120, RBC to $172 from $160, Evercore ISI to $170 from $160, JMP Securities to $175 from $145 and Raymond James to $166 from $164.
Resonant Inc. (NASDAQ: RESN) was started with a Buy rating and assigned a $6 price target (versus a $3.48 close) at Needham.
Roku Inc. (NASDAQ: ROKU) was raised to Neutral from Sell with a $36 price target at Citigroup. Roku closed up 7.9% at $34.59 on Monday and was indicated down 2.7% at $33.65 on Tuesday. Roku has a post-IPO range of $15.75 to $58.80 and a consensus price target of $38.60.
Sierra Wireless Inc. (NASDAQ: SWIR) was raised to Buy from Neutral with a $22 price target (versus a $15.80 close) at Roth Capital.
Verona Pharma PLC (NASDAQ: VRNA) was reiterated as Outperform and the price target was raised to $55 from $48 (versus a $20.97 close) at Wedbush. The target hike is based on the nebulized RPL554 for maintenance therapy of COPD having projected peak worldwide gross sales of $997 million (out in 2027). Verona Pharma has a $287 million market cap, but its shares were up 31% on Monday’s news reaction.
Monday’s top analyst calls included AMD, Broadcom, D.R. Horton, Dollar Tree, Jack in the Box, Zebra Technologies and many more.